Human tumor cell lysates as a protein source for the detection of cancer antigen-specific humoral immunity

Journal of Immunological Methods

Volumn 299, Issue 1-2, 2005, Pages 129-138

  Goodell, Vivian ^a   Disis, Mary L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antibody immunity; HER 2 neu; Lysate; p53; Tumor cell

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2 ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; PROTEIN; PROTEIN ANTIBODY; PROTEIN P53 ANTIBODY; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; CELL LYSATE; CLINICAL LABORATORY; CLINICAL MEDICINE; CONTROLLED STUDY; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STANDARD; TUMOR CELL;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; CELL EXTRACTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; RECEPTOR, ERBB-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 19444366492     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2005.02.002     Document Type: Article

References (14)

1. M. Bukhtiyarova, K. Northrop, X. Chai, D. Casper, M. Karpusas, and E. Springman Improved expression, purification, and crystallization of p38alpha MAP kinase Protein Expr. Purif. 37 2004 154
2. A. Corthay, J. Backlund, and R. Holmdahl Role of glycopeptide-specific T cells in collagen-induced arthritis: an example how post-translational modification of proteins may be involved in autoimmune disease Ann. Med. 33 2001 456
3. I.D. Davis, W. Chen, H. Jackson, P. Parente, M. Shackleton, W. Hopkins, Q. Chen, N. Dimopoulos, T. Luke, R. Murphy, A.M. Scott, E. Maraskovsky, G. McArthur, D. MacGregor, S. Sturrock, T.Y. Tai, S. Green, A. Cuthbertson, D. Maher, L. Miloradovic, S.V. Mitchell, G. Ritter, A.A. Jungbluth, Y.T. Chen, S. Gnjatic, E.W. Hoffman, L.J. Old, and J.S. Cebon Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans Proc. Natl. Acad. Sci. U. S. A. 101 2004 10697
4. M.L. Disis, E. Calenoff, G. McLaughlin, A.E. Murphy, W. Chen, B. Groner, M. Jeschke, N. Lydon, E. McGlynn, and R.B. Livingston Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer Cancer Res. 54 1994 16
5. M.L. Disis, S.M. Pupa, J.R. Gralow, R. Dittadi, S. Menard, and M.A. Cheever High titer HER-2/neu protein specific antibody immunity can be detected in patients with early stage breast cancer J. Clin. Oncol. 15 1997 3363
6. D.A. Litvak, R.K. Gupta, R. Yee, L.A. Wanek, W. Ye, and D.L. Morton Endogenous immune response to early- and intermediate-stage melanoma is correlated with outcomes and is independent of locoregional relapse and standard prognostic factors J. Am. Coll. Surg. 198 2004 27
7. W. Lutz, and E. Nowakowska-Swirta Gene p53 mutations, protein p53, and anti-p53 antibodies as biomarkers of cancer process Int. J. Occup. Med. Environ. Health 15 2002 209
8. A. Orii, H. Masutani, T. Nikaido, Y.L. Zhai, K. Kato, M. Kariya, I. Konishi, J. Yodoi, and S. Fujii Altered post-translational modification of redox factor 1 protein in human uterine smooth muscle tumors J. Clin. Endocrinol. Metab. 87 2002 3754
9. L. Salazar, and M. Disis Antibody responses to human tumor oncoproteins in cancer patients H. Stauss Y. Kawakami Tumor Antigens Recognized T Cells and Antibodies vol. 11 2002 Harwood Academic Publishers 172
10. J.W. Savopoulos, P.S. Carter, S. Turconi, G.R. Pettman, E.H. Karran, C.W. Gray, R.V. Ward, O. Jenkins, and C.L. Creasy Expression, purification, and functional analysis of the human serine protease HtrA2 Protein Expr. Purif. 19 2000 227
11. H. Shimada, T. Ochiai, and F. Nomura Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group Cancer 97 2003 682
12. O. Tureci, U. Luxemburger, H. Heinen, U. Mack, G.W. Sybrecht, C. Huber, and U. Sahin CrELISA: a fast and robust enzyme-linked immunosorbent assay bypassing the need for purification of recombinant protein J. Immunol. Methods 289 2004 191
13. R.L. Ward, N.J. Hawkins, D. Coomber, and M.L. Disis Antibody immunity to the HER-2/neu oncogenic protein in patients with colorectal cancer Hum. Immunol. 60 1999 510
14. K. Webley, J.A. Bond, C.J. Jones, J.P. Blaydes, A. Craig, T. Hupp, and D. Wynford-Thomas Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage Mol. Cell. Biol. 20 2000 2803